At a glance
ClinicalIndex Comparison RecordN/ACompleted· 23 enrolled
Drug / intervention
Multispectral Optoacoustic Tomography (MSOT)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non Invasive Characterization of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography
University of Erlangen-Nürnberg Medical School·observational·Posted Dec 3, 2020·Updated Apr 18, 2023
In Brief
An observational study evaluating Multispectral Optoacoustic Tomography (MSOT) for Crohn's Disease and 2 related conditions. Completed, enrolled 23 participants across 1 site.
Detailed Summary
Monocentric, prospective observational study to assess bowel inflammation in children with chronic inflammatory bowel disease (IBD) using multispectral optoacoustic tomography (MSOT).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCrohn's Disease, Ulcerative Colitis, IBD
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedDec 2020
Enrollment StartMar 2021
Primary CompletionDec 2022
TodayJul 2026
First PostedDec 3, 2020
Enrollment StartMar 22, 2021
Primary CompletionDec 20, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 5.6 years ago
Interventions
Multispectral Optoacoustic Tomography (MSOT)device
Non-invasive transcutaneous MSOT imaging of the bowel wall (terminal ileum, ascending caecum/colon, transverse colon, descending colon, and sigmoid colon).